BFC Planning’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
BFC Planning's HQL Position: Q3 2026 in Review
BFC Planning increased its abrdn Life Sciences Investors (HQL) stake by 3.2% in Q3 2026, buying an estimated $5.7K and bringing the position to 9,223 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #988.
BFC Planning first reported a position in HQL in Q3 2024 and has held it in 9 quarters since. The position peaked at $179K in Q2 2026. 74 funds tracked by Wall St. Rank hold HQL as of Q3 2026.
- BFC Planning held 9,223 shares of abrdn Life Sciences Investors worth $172K as of Q3 2026.
- BFC Planning bought 282 abrdn Life Sciences Investors shares in Q3 2026, an estimated $5.7K.
- abrdn Life Sciences Investors made up 0.01% of BFC Planning's portfolio in Q3 2026, its #988 holding.
- BFC Planning first reported a position in abrdn Life Sciences Investors in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's abrdn Life Sciences Investors position peaked at $179K in Q2 2026.
- 74 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.